These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer. Lee DH; Kim SH; Joo I; Hur BY; Han JK Eur J Radiol; 2016 Jun; 85(6):1085-91. PubMed ID: 27161056 [TBL] [Abstract][Full Text] [Related]
46. Staging of Cervical Cancer: A Practical Approach Using MRI and FDG PET. Lakhman Y; Aherne EA; Jayaprakasam VS; Nougaret S; Reinhold C AJR Am J Roentgenol; 2023 Nov; 221(5):633-648. PubMed ID: 37459457 [TBL] [Abstract][Full Text] [Related]
47. Integrated PET/MRI for whole-body staging of patients with primary cervical cancer: preliminary results. Grueneisen J; Schaarschmidt BM; Heubner M; Aktas B; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1814-24. PubMed ID: 26199113 [TBL] [Abstract][Full Text] [Related]
49. The role of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG-PET) in the diagnosis of recurrence and lymph node metastasis of cervical cancer. Umesaki N; Tanaka T; Miyama M; Kawabe J; Okamura T; Koyama K; Ochi H; Ogita S Oncol Rep; 2000; 7(6):1261-4. PubMed ID: 11032926 [TBL] [Abstract][Full Text] [Related]
50. Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: comparison with CT and MRI findings. Inubashiri E; Hata K; Kanenishi K; Shiota A; Ohno M; Yamamoto Y; Nishiyama Y; Ohkawa M; Hata T J Obstet Gynaecol Res; 2009 Feb; 35(1):26-34. PubMed ID: 19215544 [TBL] [Abstract][Full Text] [Related]
51. Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched study. Vandecasteele K; Delrue L; Lambert B; Makar A; Lambein K; Denys H; Tummers P; Van den Broecke R; Villeirs G; De Meerleer G Int J Gynecol Cancer; 2012 May; 22(4):630-7. PubMed ID: 22237382 [TBL] [Abstract][Full Text] [Related]
52. Dual-phase F-18 FDG PET-CT in staging and lymphoscintigraphy for detection of sentinel lymph nodes in oral cavity cancers. Sürücü E; Polack BD; Demir Y; Durmuşoğlu M; Ekmekçi S; Sarıoğlu S; Çelik AO; Ada E; İkiz AÖ Clin Imaging; 2015; 39(5):781-6. PubMed ID: 25721710 [TBL] [Abstract][Full Text] [Related]
53. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study. Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098 [TBL] [Abstract][Full Text] [Related]
54. Isolated mediastinal lymph node false positivity of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical cancer. Onal C; Oymak E; Findikcioglu A; Reyhan M Int J Gynecol Cancer; 2013 Feb; 23(2):337-42. PubMed ID: 23358181 [TBL] [Abstract][Full Text] [Related]
55. Simultaneous [18F]FDG-PET/MRI: Correlation of Apparent Diffusion Coefficient (ADC) and Standardized Uptake Value (SUV) in Primary and Recurrent Cervical Cancer. Brandmaier P; Purz S; Bremicker K; Höckel M; Barthel H; Kluge R; Kahn T; Sabri O; Stumpp P PLoS One; 2015; 10(11):e0141684. PubMed ID: 26551527 [TBL] [Abstract][Full Text] [Related]
56. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study. Li K; Sun H; Guo Q Eur J Radiol; 2019 Apr; 113():153-157. PubMed ID: 30927941 [TBL] [Abstract][Full Text] [Related]
57. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796 [TBL] [Abstract][Full Text] [Related]
58. Feasibility and diagnostic performance of hybrid PET/MRI compared with PET/CT for gynecological malignancies: a prospective pilot study. Schwartz M; Gavane SC; Bou-Ayache J; Kolev V; Zakashansky K; Prasad-Hayes M; Taouli B; Chuang L; Kostakoglu L Abdom Radiol (NY); 2018 Dec; 43(12):3462-3467. PubMed ID: 29948057 [TBL] [Abstract][Full Text] [Related]
59. Diagnostic value of Tsuyoshi H; Tsujikawa T; Yamada S; Okazawa H; Yoshida Y Cancer Imaging; 2020 Oct; 20(1):75. PubMed ID: 33092631 [TBL] [Abstract][Full Text] [Related]
60. [Prognostic value of pretherapeutic 18F-FDG PET/CT in cancer of the uterine cervix: a retrospective study of 53 patients]. Chastan M; Manrique A; Baron M; Sanson AE; Diologent B; Vera P; Hitzel A Gynecol Obstet Fertil; 2010 Apr; 38(4):244-9. PubMed ID: 20359931 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]